Navigation Links
Biting back: Research could lead to mosquitoes being susceptible to diseases they transmit
Date:5/17/2011

MANHATTAN, Kan. -- Mosquitoes are becoming more resistant to current pesticides. That's troubling to Kansas State University biologist Kristin Michel, as it means malaria and other mosquito-borne diseases will continue spreading. A recent grant from the National Institutes of Health may change all that.

Michel, an assistant professor of biology, is using the nearly $1.5 million grant for the four-year study, "The function(s) of serpin-2 in mosquito immunity and physiology." Findings from this investigation into the role of the serpin-2 molecule in Anopheles gambiae -- the African malaria mosquito -- could stop the transmission of malaria and other mosquito-spread diseases by making mosquitoes susceptible to the very diseases they transmit.

As principal investigator, Michel and her laboratory team are focusing on definitively understanding the role of serpin-2 in the mosquito's body. Serpins are a group of similarly structured proteins that can inhibit a group of enzymes that break down proteins called proteases. Serpin-2 controls certain proteases that create immunity against bacteria and fungi in the mosquito.

"Current insecticides used for controlling vector-borne diseases are chemicals that target an insect's nervous system," Michel said. "Because serpin-2 relates to a mosquito's immunity, it could act as a novel insecticide target."

Attacking this molecule could avoid or disrupt a response from the mosquito's immune system that would otherwise protect the insect, she said.

The idea for the research came from a previous project conducted by Michel and fellow Kansas State researchers. By removing serpin-2 from the mosquitoes' bodies, the researchers noticed melanization is affected. In insects melanin is used to encompass foreign objects that enter their body, like bacteria and parasites. This process prevents the insect's immune system from constantly fighting the foreign body. It also causes pseudo-tumors
'/>"/>

Contact: Kristin Michel
kmichel@k-state.edu
785-532-0161
Kansas State University
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Inhibiting prostate cancer without disturbing regular body processes
2. Inhibiting fatty acids in immune cells decreases atherosclerosis risk
3. Canadian EMR Vendor Nightingale Exhibiting at Spring 2010 Canada Health Infoway Partnership Conference
4. Bitrex Bitter Safety Additive Exhibiting at the Safe Kids Fair 2010; Making a Bitter Face to Learn about Poisoning Prevention
5. Philanthropist connects strategic plan to research
6. Research Shows Early Onset Alzheimers Disease Sometimes Missed
7. Ohio residents: Medical and health research important to states economy, jobs and incomes
8. Researchers examine procedure utilization trends in patients with clinically localized renal masses
9. Researchers identify DNA region linked to depression
10. Researchers move closer to identifying new class of asthma, COPD drugs
11. Research breakthrough on male infertility
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2015)... ... 29, 2015 , ... "I have been a licensed physical ... specialize in manual therapy, and my invention will provide headache sufferers a solution ... muscle dysfunction throughout the body." , They developed THE RELIEVER to alleviates headaches, ...
(Date:8/29/2015)... ... August 29, 2015 , ... Next weekend is Labor Day weekend, ... officially ends on September 22nd this year). For IT security personnel, it should also ... which could prove far more costly than a simple headache. , Joe Caruso, founder ...
(Date:8/29/2015)... ... August 29, 2015 , ... Vascular Health Sciences ... sell Arterosil and Arterosil HP, and that all claims and counterclaims have been ... Sciences, LLC (VHS) in the United States District Court for the Southern District ...
(Date:8/28/2015)... ... , ... The Kentucky State Department of Workforce Investment Commissioner Beth Kuhn recently ... for, they are unable to pass the initial drug test and therefore unable to ... order to be able to hire long-term, skilled talent. (1) Will Wesch, Director of ...
(Date:8/28/2015)... ... August 28, 2015 , ... As reported by ... received FDA clearance for results that last for two years, the longest of ... for patients who are looking for a long-lasting, effective solution for their cellulite, according ...
Breaking Medicine News(10 mins):Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 3Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 4Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 4Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 2Health News:Maryland Dermatologists Discuss Non-Invasive Cellulite Reduction System Cellfina Receiving 2-Year FDA Clearance 3
... to have a higher risk of developing late age-related ... to a report in the July issue of Archives ... Age-related macular degeneration (AMD) [a progressive eye disease that ... leading cause of blindness in the Western world, according ...
... an enzyme that inactivates two tumor-suppressing genes, ultimately triggering ... cells, researchers at The University of Texas M. D. ... the journal Cell. , "This is a completely new ... for clinical intervention," senior author Mien-Chie Hung, Ph.D., professor ...
... August 2007) could lead to a change of paradigm in ... resonance imaging (MRI) is substantially more accurate than mammography in ... now MRI was thought to be hardly suited for the ... at the University of Bonn have now come to a ...
... to rid the brain of the amyloid buildup that plagues ... the method outlined in a paper published online August 12 ... Center show how the bodys natural way of ridding the ... disease. Then the team demonstrated an experimental method in mice ...
... 2007 - In an Editorial, to be published ... http://intl.elsevierhealth.com/journals/joca/ ), published by Elsevier, a panel of ... nonsteroidal anti-inflammatory drugs (NSAIDs) must remain a significant ... osteoarthritis (OA). The Editorial summarizes the outcomes of ...
... to leaders of the U.S. House of Representatives Ways ... of the American College of Physicians (ACP) today expressed ... Act of 2007 (H.R. 3162). Representing 124,000 internal medicine ... medical specialty society in the United States. , ...
Cached Medicine News:Health News:Smoking may strongly increase long-term risk of eye disease 2Health News:Pathway links inflammation, angiogenesis and breast cancer 2Health News:Pathway links inflammation, angiogenesis and breast cancer 3Health News:MRI finds breast cancer before it becomes dangerous 2Health News:MRI finds breast cancer before it becomes dangerous 3Health News:Draining away brain's toxic protein to stop Alzheimer's 2Health News:Draining away brain's toxic protein to stop Alzheimer's 3Health News:Using coxibs and NSAIDs to treat osteoarthritis 2Health News:Support for Children's Health and Medicare Protection Act given to House leaders by ACP 2
(Date:8/28/2015)... Aug. 28, 2015 ... the addition of the "Investigation Report on ... offering. Originally discovered by Welfide (Mitsubishi ... Industries, Ltd) as an inflammatory drug, pranoprofen was ... Co., Ltd under the trade name of pranopulin ...
(Date:8/28/2015)... , Aug. 28, 2015 Patterson ... Inc. (Nasdaq: PDCO ), is now an ... announced acquisition of Patterson Medical by Madison Dearborn ... retain its name for a transition period before ... rehabilitation and sports medicine products.  With the focused ...
(Date:8/28/2015)... -- The scientific team of a new biotech ... leading academics in the field of aging Prof. Robert ... extension for model animals - 10 fold for nematodes) has ... diseases, primarily, around the stability and stress resistance of certain ... "Stability analysis of a model gene network links aging, stress ...
Breaking Medicine Technology:Investigation Report on China's Pranoprofen Market, 2010-2019 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 2Patterson Medical Positioned for Continued Growth as a Newly Independent Company 3Gero: Physics Meets Biology to Help Defeat Aging 2Gero: Physics Meets Biology to Help Defeat Aging 3
... subset analyses of progression-free survival in,the SPARC ... in,relative risk of disease progression for patients ... as well as presence or absence of ... Pharmion,Corporation and GPC Biotech AG today announced ...
... Results in Improved Long-term [Five-years],Overall Survival for ... 2007 /PRNewswire-FirstCall/ -- FOLFOX4, an,Eloxatin(R)-based chemotherapy regimen, ... survival (OS) and,time to disease progression (TTP) ... in patients with metastatic (advanced) colorectal cancer.,Importantly, ...
Cached Medicine Technology:Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 2Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 3Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 4Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 5Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 6Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 7Eloxatin (oxaliplatin injection)-Based Chemotherapy Sets New,Treatment Benchmark in Patients With Metastatic Colorectal Cancer 2Eloxatin (oxaliplatin injection)-Based Chemotherapy Sets New,Treatment Benchmark in Patients With Metastatic Colorectal Cancer 3Eloxatin (oxaliplatin injection)-Based Chemotherapy Sets New,Treatment Benchmark in Patients With Metastatic Colorectal Cancer 4
The adult underbody blanket is conveniently positioned on the table before the patient arrives to the procedure suite....
The adult blanket provides full coverage for patients of all sizes. The generous size and versatility of these blankets include extra material for the shoulders and feet. The foot drape also reduces ...
The Bair Hugger outpatient blanket makes it easy to give your patients the benefit of prewarming and enhance patient comfort during outpatient procedures....
The full body blanket provides coverage to the entire patient....
Medicine Products: